| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.015 | 11.282 | 14.117 | 7.367 | 0 |
| Total Income - EUR | - | - | - | - | - | 1.015 | 11.462 | 14.121 | 7.367 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 330 | 2.958 | 7.157 | 5.197 | 3.848 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 685 | 8.503 | 6.965 | 2.170 | -3.848 |
| Net Profit/Loss - EUR | - | - | - | - | - | 655 | 8.160 | 6.605 | 1.867 | -3.848 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Endomed Dr Lacatusu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 19 | 15.155 | 11.320 | 7.417 | 3.527 |
| Current Assets | - | - | - | - | - | 990 | 428 | 4.430 | 9.876 | 9.821 |
| Inventories | - | - | - | - | - | 0 | 8 | 9 | 8 | 8 |
| Receivables | - | - | - | - | - | 0 | 79 | 112 | 378 | 376 |
| Cash | - | - | - | - | - | 990 | 340 | 4.309 | 9.489 | 9.436 |
| Shareholders Funds | - | - | - | - | - | 696 | 8.840 | 15.473 | 17.292 | 13.348 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 312 | 6.743 | 278 | 0 | 0 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endomed Dr Lacatusu S.r.l.